Kiora Pharmaceuticals, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 17 →InsidersNo open-market buys or sales.→HoldersPerceptive 9.9%Adar1 3.8%Citadel 2.6%→Financing →
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$162,390last 12 months
- Operating cash flow
- −$10.4Mlast 12 months
- Cash and equivalents
- $7.1Mat the last balance sheet
- Shares outstanding
- 4.4M shareson issue